NADH and NADPH pharmaceuticals for treating hypertension

Details NADH and NADPH pharmaceuticals for treating hypertension NADH and NADPH pharmaceuticals for treating hypertension

1996-05-08

1997-09-16

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 46, A61K 3170

Patent

active

056681143

ABSTRACT:
A method for lowering high blood pressure includes the step of administering the reduced form of nicotinamide adenine dinucleotide (NADH) or the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or physiologically compatible salts of NADH and/or NADPH. Patients so treated exhibit a significant reduction of their elevated blood pressure over time. The method is effective in treating hypertension and chronic hypertension.

REFERENCES:
patent: 4497826 (1985-02-01), Narabayashi et al.
patent: 4970200 (1990-11-01), Birkmayer et al.
patent: 5019561 (1991-05-01), Birkmayer et al.
patent: 5037821 (1991-08-01), Horovitz
patent: 5106831 (1992-04-01), Fisher et al.
patent: 5332727 (1994-07-01), Birkmayer
patent: 5444053 (1995-08-01), Birkmayer

Affiliated with

Also associated with

Rating

NADH and NADPH pharmaceuticals for treating hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NADH and NADPH pharmaceuticals for treating hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NADH and NADPH pharmaceuticals for treating hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-218241